Stability Indicating RP-UPLC Method for Simultaneous Estimation of Emtricitabine, Tenofovir and Bictegravir in Bulk and Pharmaceutical Dosage Form

被引:1
作者
Konam, Kishore [1 ]
Reddy, Kanala Somasekhar [2 ]
机构
[1] JNTUA, Ananthapuramu 515002, Andhra Pradesh, India
[2] Raghavendra Inst Pharmaceut Educ & Res, Dept Pharmacol, Anantapuramu 515002, Andhra Pradesh, India
来源
INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH | 2020年 / 10卷 / 05期
关键词
simultaneous estimation; Emtricitabine; TenofovirAlafenamide; Bictegravir and Acquity BEH C-18; PDA Detector; ICH Validation;
D O I
10.22376/ijpbs/lpr.2020.10.5.P90-101
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The Proposed Sensitive, specific, Linear, accurate, precise and Robust method was developed for the simultaneous estimation of the Emtricitabine, Tenofovir Alafenamide and Bictegravir in bulk and Pharmaceutical tablet dosage form by Ultra performance liquid Chromatography. For the Optimised method, Chromatogram was run through AcquityBEH (Bridged Ethylene hybrid) C-18 130A degrees (100mm x 2.1 mm, 1.7 mu m) column at a flow rate of 0.5 mL/min and pH 3.0 buffer Triethylamine(TEA) was used in this method. The Column oven temperature was maintained at 40 degrees C and the working wavelength was selected at 280 nm. The retention time of Emtricitabine, Tenofovir Alafenamide and Bictegravir were found to be 2.6 min, 4.3 min and 5.2 min respectively. The percentage RSD ( Relative standard deviation) of the method precision for Emtricitabine, Tenofovir Alafenamide and Bictegravir were found to be 0.31%, 0.02% and 0.17% respectively. Percentage Recovery was obtained as 99.8%, 100.2% and 100.7% for Emtricitabine, Tenofovir Alafenamide and Bictegravir respectively. Linearity was obtained as 0.999, 0.999 and 0.999 for Emtricitabine, Tenofovir, Alafenamide and Bictegravir respectively. Analytical Range was found from the linearity and accuracy for Emtricitabine was 100 mu g/mL to 300 mu g/mL, Tenofovir Alafenamide was 12.5 mu g/mL to 37.5 mu g/mL and Bictegravir was 25 mu g/mL to 75 mu g/mL. Method is stability indicating because in forced degradation studies all main analytes peak purities were passed and no blank and Placebo interferences at the retention time of the main analytes. Thus the present method was developed by using low-cost solvent in ratio of TEA buffer pH 3.0.: Methanol (45:55 v/v), detected by using photodiode array detector which was highly sensitive to detect at a lower concentration. The use of mobile phase as an extracting solvent makes it more compatible with the developed method. So the proposed research method was sensitive, specific, accurate, precise, linear, and robust and this method can be used for routine and stability analysis in quality control for reduction of time and cost. The existing methods were not cost effective due to the use of highly sophisticated detectors, Expensive (high cost) solvents such as Tetrahydrofuran and some methods were found to be less sensitive.
引用
收藏
页码:P90 / P101
页数:12
相关论文
共 50 条
  • [31] STABILITY INDICATING RP-HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF ENIITRICITABINE, TENOFOVIR, COBICISTAT AND ELVITEGRAVIR
    Sudha, P. D. Chaithanya
    Sohail, P.
    Avulapati, Ushashree
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2020, 11 (03): : 1452 - 1466
  • [32] Stability-indicating high-performance thin-layer chromatography method for the simultaneous estimation of emtricitabine and tenofovir alafenamide fumarate
    Arun M. Kashid
    Rohini R. Kadam
    [J]. JPC – Journal of Planar Chromatography – Modern TLC, 2021, 34 : 253 - 261
  • [33] Stability-indicating high-performance thin-layer chromatography method for the simultaneous estimation of emtricitabine and tenofovir alafenamide fumarate
    Kashid, Arun M.
    Kadam, Rohini R.
    [J]. JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC, 2021, 34 (03) : 253 - 261
  • [34] Chemometrics-assisted spectrophotometric method development and validation for simultaneous estimation of emtricitabine, tenofovir alafenamide fumarate, and dolutegravir sodium in dosage form
    Rathod, Sapna
    Patel, Paresh
    [J]. JOURNAL OF REPORTS IN PHARMACEUTICAL SCIENCES, 2022, 11 (01): : 41 - 50
  • [35] UPLC Method for Simultaneous Separation and Estimation of Secnidazole, Fluconazole and Azithromycin in Pharmaceutical Dosage Forms
    Yanamandra, Ramesh
    Chaudhary, Avinash
    Bandaru, Srinivasa Rao
    Patro, Balaram
    Murthy, Y. L. N.
    Ramaiah, Parimi Atchuta
    Sastry, C. S. P.
    [J]. E-JOURNAL OF CHEMISTRY, 2010, 7 : S363 - S371
  • [36] STABILITY-INDICATING RP-HPLC-PDA METHOD FOR THE SIMULTANEOUS ANALYSIS OF TERBUTALINE SULPHATE AND DOXOFYLLINE IN BULK AND TABLET DOSAGE FORMS
    Sunandana, B.
    Sushmitha, K.
    Nalluri, Buchi N.
    [J]. JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2014, 37 (09) : 1257 - 1269
  • [37] Stability-indicating Simultaneous HPTLC Method for Olanzapine and Fluoxetine in Combined Tablet Dosage Form
    Shah, C. R.
    Suhagia, B. N.
    Shah, N. J.
    Patel, D. R.
    Patel, N. M.
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 70 (02) : 251 - U9
  • [38] Stability indicating LC method for estimation of Formoterol fumarate and Mometasone furoate in respicaps dosage form
    Jain, H. K.
    Bhangale, P. R.
    Satam, S. S.
    [J]. INDIAN JOURNAL OF CHEMICAL TECHNOLOGY, 2016, 23 (05) : 405 - 411
  • [39] Method Development and Validation of antiviral combination as Ritonavir and Lopinavir in Bulk and Pharmaceutical Dosage Form by RP-HPLC
    Rane, S. S.
    Chaudhari, R. Y.
    Patil, V. R.
    [J]. RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2015, 6 (05): : 982 - 987
  • [40] RP-HPLC METHOD DEVELOPMENT AND VALIDTION FOR SIMULTANEOUS ESTIMATION OF TELMISARTAN AND RAMIPRIL IN PHARMACEUTICAL DOSAGE FORMS
    Divya, M.
    Anusha, G.
    Padmalatha, H.
    [J]. INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 3 (02): : 86 - 91